MRK
Price
$99.39
Change
+$0.02 (+0.02%)
Updated
Dec 24, 02:00 PM (EDT)
42 days until earnings call
SNYNF
Price
$94.35
Change
-$0.40 (-0.42%)
Updated
Dec 23 closing price
Ad is loading...

MRK vs SNYNF

Header iconMRK vs SNYNF Comparison
Open Charts MRK vs SNYNFBanner chart's image
Merck & Co
Price$99.39
Change+$0.02 (+0.02%)
VolumeN/A
CapitalizationN/A
Sanofi
Price$94.35
Change-$0.40 (-0.42%)
Volume$339
CapitalizationN/A
MRK vs SNYNF Comparison Chart
Loading...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRK vs. SNYNF commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRK is a Buy and SNYNF is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (MRK: $99.45 vs. SNYNF: $94.35)
Brand notoriety: MRK: Notable vs. SNYNF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: MRK: 31% vs. SNYNF: 33%
Market capitalization -- MRK: $331.75B vs. SNYNF: $134.16B
MRK [@Pharmaceuticals: Major] is valued at $331.75B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRK’s FA Score shows that 1 FA rating(s) are green whileSNYNF’s FA Score has 2 green FA rating(s).

  • MRK’s FA Score: 1 green, 4 red.
  • SNYNF’s FA Score: 2 green, 3 red.
According to our system of comparison, MRK is a better buy in the long-term than SNYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRK’s TA Score shows that 5 TA indicator(s) are bullish while SNYNF’s TA Score has 4 bullish TA indicator(s).

  • MRK’s TA Score: 5 bullish, 3 bearish.
  • SNYNF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both MRK and SNYNF are a good buy in the short-term.

Price Growth

MRK (@Pharmaceuticals: Major) experienced а -0.61% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was -4.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.40%. For the same industry, the average monthly price growth was -2.78%, and the average quarterly price growth was -2.25%.

Reported Earning Dates

MRK is expected to report earnings on Feb 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.40% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRK($332B) has a higher market cap than SNYNF($134B). MRK has higher P/E ratio than SNYNF: MRK (935.64) vs SNYNF (14.04). SNYNF YTD gains are higher at: -5.285 vs. MRK (-6.364). SNYNF has higher annual earnings (EBITDA): 13.8B vs. MRK (6.91B). SNYNF has more cash in the bank: 7.99B vs. MRK (7.09B). SNYNF has less debt than MRK: SNYNF (21B) vs MRK (35.1B). MRK has higher revenues than SNYNF: MRK (60.1B) vs SNYNF (46.1B).
MRKSNYNFMRK / SNYNF
Capitalization332B134B248%
EBITDA6.91B13.8B50%
Gain YTD-6.364-5.285120%
P/E Ratio935.6414.046,662%
Revenue60.1B46.1B130%
Total Cash7.09B7.99B89%
Total Debt35.1B21B167%
FUNDAMENTALS RATINGS
MRK vs SNYNF: Fundamental Ratings
MRK
SNYNF
OUTLOOK RATING
1..100
886
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
3996
SMR RATING
1..100
3481
PRICE GROWTH RATING
1..100
6172
P/E GROWTH RATING
1..100
10028
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYNF's Valuation (9) in the null industry is in the same range as MRK (17) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to MRK’s over the last 12 months.

MRK's Profit vs Risk Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNYNF (96) in the null industry. This means that MRK’s stock grew somewhat faster than SNYNF’s over the last 12 months.

MRK's SMR Rating (34) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNYNF (81) in the null industry. This means that MRK’s stock grew somewhat faster than SNYNF’s over the last 12 months.

MRK's Price Growth Rating (61) in the Pharmaceuticals Major industry is in the same range as SNYNF (72) in the null industry. This means that MRK’s stock grew similarly to SNYNF’s over the last 12 months.

SNYNF's P/E Growth Rating (28) in the null industry is significantly better than the same rating for MRK (100) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew significantly faster than MRK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MRKSNYNF
RSI
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
50%
Momentum
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
46%
Advances
ODDS (%)
Bullish Trend 12 days ago
47%
Bullish Trend 16 days ago
52%
Declines
ODDS (%)
Bearish Trend 14 days ago
50%
N/A
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
57%
Bullish Trend 2 days ago
55%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bearish Trend 2 days ago
46%
View a ticker or compare two or three
Ad is loading...
MRK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPID0.910.01
+1.32%
Rapid Micro Biosystems
JXN89.100.82
+0.93%
Jackson Financial
EVI17.430.01
+0.06%
EVI Industries
HOPE12.34-0.03
-0.24%
Hope Bancorp
AXON624.14-7.55
-1.20%
Axon Enterprise

MRK and

Correlation & Price change

A.I.dvisor tells us that MRK and AZN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRK and AZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+1.35%
AZN - MRK
30%
Poorly correlated
+1.96%
GSK - MRK
24%
Poorly correlated
+1.37%
NVS - MRK
22%
Poorly correlated
+1.38%
BIIB - MRK
21%
Poorly correlated
+1.99%
SNYNF - MRK
20%
Poorly correlated
-0.43%
More

SNYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNYNF has been loosely correlated with SNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNYNF jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
-0.43%
SNY - SNYNF
37%
Loosely correlated
+1.43%
NVSEF - SNYNF
24%
Poorly correlated
+0.84%
AZN - SNYNF
23%
Poorly correlated
+1.96%
JNJ - SNYNF
22%
Poorly correlated
+0.55%
NVS - SNYNF
21%
Poorly correlated
+1.38%
More